BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  In “Pursuit of Passions,” Ironwood CEO Will Step Down

  He will be replaced on an interim-basis by Thomas McCourt, who currently serves as company president.

  February 9, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Lilly CFO Resigns Due to “Inappropriate Communication” with Multiple Employees

  Anat Ashkenazi was tapped to take over as chief financial officer of Eli Lilly following the abrupt resignation of Josh Smiley, who departed the company following allegations of an inappropriate relationship with an employee.

  February 9, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Money on the Move: February 3-9

  The cash just keeps coming for biopharma companies. Here’s a rundown of some of this week’s investment dollar recipients.

  February 9, 2021

   · 

  6 min read

   · 

  Kate Goodwin
• 

  Drug Development

  COVID-19 Long-Hauler Therapy Space Beginning to Take Shape

  While the space is just beginning to emerge, therapies for long-haul COVID-19 patients are still very much an unmet need.

  February 9, 2021

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Are Two Better Than One? Expert Weighs in on Double Masking

  Ever since Dr. Fauci said he often double masks and that two masks “just makes common sense,” the medical community has been in somewhat of a debate with many in agreement, and some saying the opposite.

  February 9, 2021

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Business

  Rebuilding the FDA: Who Will Be Its Next Leader?

  The choice for the new FDA commissioner will tell the public about the Biden administration’s battle plan with regards to handling the global pandemic.

  February 9, 2021

   · 

  2 min read

   · 

  Kristiane Polido
• 

  Job Trends

  Life Sciences Job Expansions Continue to Soar Throughout Pandemic

  Here’s a recap of companies announcing facility expansions this past month and life sciences job creations across the nation.

  February 9, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug

  A final analysis of the Phase III TITAN study shows that Janssen’s ERLEADA®, when added to androgen deprivation therapy, significantly improved overall survival in patients with metastatic castration-sensitive prostate cancer (mCSPC) compared with placebo.

  February 9, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  BigHat Plans to Take Antibody Engineering to a Whole New Level

  BigHat is a Bay-area startup that’s reimagining antibody development with the help of AI and ML (machine learning) technologies through data-driven discovery.

  February 9, 2021

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Cancer Drug Fights COVID-19 Respiratory Deaths in Hospital Trial

  Veru announced positive results from its Phase II trial of its VERU-111 compared to placebo in hospitalized patients at high risk for Acute Respiratory Distress Syndrome (ARDS) from COVID-19.

  February 9, 2021

   · 

  4 min read

   · 

  Mark Terry